SCHEMBL808754

SCHEMBL808754

COc1[c]cc2c(OC)cccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 3/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
MAOA P21397 2/20 0.37
NQO2 P16083 1/20 0.37
ACHE P22303 5/20 0.36
BCHE P06276 4/20 0.36
FLT3 P36888 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2074144 0.86 NQO1 (0.46) NQO1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL15352430 0.81 CYP1A2 (0.39) NQO1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL15353313 0.81 ACHE (0.35) NQO1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL29919905 0.76 NQO1 (0.67) NQO1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8393507 0.76 NQO1 (0.67) NQO1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL315486 0.75 CYP1A2 (0.45) NQO1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL8391116 0.74 ALDH1A1 (0.59) NQO1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL29862025 0.74 ALDH1A1 (0.59) NQO1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL2253565 0.72 CYP1A2 (0.42) NQO1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL21830291 0.71 PDE4A (0.42) KDM4EALDH1A1SMN1; SMN2MAPTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8937152-B2 Non-selective somatostatin analogues ITALFARMACO SPA (IT) 2015-01-20 US claimed
EP-2225271-B1 NEW NON-SELECTIVE SOMATOSTATIN ANALOGUES ITALFARMACO SPA (IT) 2013-07-31 EP claimed
US-20100323964-A1 NEW NON-SELECTIVE SOMATOSTATIN ANALOGUES ITALFARMACO SPA (IT) 2010-12-23 US claimed
EP-2225271-A2 NEW NON-SELECTIVE SOMATOSTATIN ANALOGUES ITALFARMACO S.p.A. (IT) 2010-09-08 EP claimed
WO-2009071460-A2 NEW NON-SELECTIVE SOMATOSTATIN ANALOGUES ITALFARMACO SPA (IT) 2009-06-11 WO claimed
EP-2067786-A1 Novel non selective analogs of somatostatin ITALFARMACO S.p.A. (IT) 2009-06-10 EP claimed
US-8937152-B2 Non-selective somatostatin analogues ITALFARMACO SPA (IT) 2015-01-20 US disclosed
EP-2225271-B1 NEW NON-SELECTIVE SOMATOSTATIN ANALOGUES ITALFARMACO SPA (IT) 2013-07-31 EP disclosed
EP-1593674-B1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2011-07-20 EP disclosed
US-20100323964-A1 NEW NON-SELECTIVE SOMATOSTATIN ANALOGUES ITALFARMACO SPA (IT) 2010-12-23 US disclosed
EP-2225271-A2 NEW NON-SELECTIVE SOMATOSTATIN ANALOGUES ITALFARMACO S.p.A. (IT) 2010-09-08 EP disclosed
US-7683215-B2 Optically active bisoxazoline compounds, process for production of the same and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-23 US disclosed
US-7671213-B2 Optically active bisoxazoline compounds, process for production of the same and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-02 US disclosed
US-20080076931-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF ITAGAKI MAKOTO 2008-03-27 US disclosed
US-20080076941-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF ITAGAKI MAKOTO 2008-03-27 US disclosed
CN-101125833-A Optically active bisoxazoline compounds, process for production of the same and use thereof SUMITOMO CHEMICAL CO (JP) 2008-02-20 CN disclosed
US-7288674-B2 Optically active bisoxazoline compounds, process for production of the same and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-10-30 US disclosed
US-20060149077-A1 Optically active bisoxazoline compounds, process for production of the same and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-06 US disclosed
CN-1771236-A Optically active bisoxazoline compound, process for producing the same, and use thereof SUMITOMO CHEMICAL CO (JP) 2006-05-10 CN disclosed
EP-1593674-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060149077-A1 Optically active bisoxazoline compounds, process for production of the same and use thereof ACSL3, ADSL, SQLE NQO1 434/4885KDM4E 3069/4885ALDH1A1 897/4885
US-20080076941-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF ACSL3, ADSL, SQLE NQO1 434/4885KDM4E 3069/4885ALDH1A1 897/4885
US-20100323964-A1 NEW NON-SELECTIVE SOMATOSTATIN ANALOGUES SSTR4, SSTR1, SSTR3 NQO1 4885/4885KDM4E 3796/4885ALDH1A1 4424/4885
US-20080076931-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF ACSL3, ADSL, SQLE NQO1 434/4885KDM4E 3069/4885ALDH1A1 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.